Literature DB >> 1807820

Ophthalmic features of giant cell arteritis.

S S Hayreh.   

Abstract

Giant cell arteritis (GCA) is an ophthalmic emergency because, if undetected or managed inadequately, there is a high risk of developing a painless, permanent blindness in one or both eyes; however, if it is quickly identified and treated urgently and aggressively, blindness is almost entirely preventable. The ocular manifestations of GCA are essentially ischaemic in nature, with blindness as the most dreaded complication. Blindness is usually due to anterior ischaemic optic neuropathy (AION) and occasionally to other causes, e.g. posterior ischaemic optic neuropathy or central retinal or cilioretinal artery occlusion, although extremely rarely it may be cortical in origin. Diplopia and other types of ophthalmoplegias are seen in some cases but are usually transient in nature. Ischaemic lesions of the anterior segment of the eye are also seen in a few cases. Diagnosis of arteritic AION is discussed at length. Finally, management of GCA from the point of view of visual loss is discussed in detail.

Entities:  

Mesh:

Year:  1991        PMID: 1807820     DOI: 10.1016/s0950-3579(05)80064-0

Source DB:  PubMed          Journal:  Baillieres Clin Rheumatol        ISSN: 0950-3579


  4 in total

1.  Steroid management in giant cell arteritis.

Authors:  C C Chan; M Paine; J O'Day
Journal:  Br J Ophthalmol       Date:  2001-09       Impact factor: 4.638

Review 2.  Giant cell arteritis. Epidemiology and treatment.

Authors:  E Nordborg; R Andersson; B A Bengtsson
Journal:  Drugs Aging       Date:  1994-02       Impact factor: 3.923

3.  Population-based Rate and Patterns of Diplopia in Giant Cell Arteritis.

Authors:  Clara M Castillejo Becerra; Cynthia S Crowson; Matthew J Koster; Kenneth J Warrington; M Tariq Bhatti; John J Chen
Journal:  Neuroophthalmology       Date:  2021-08-20

4.  The Utility of Color Duplex Ultrasonography in the Diagnosis of Giant Cell Arteritis: A Prospective, Masked Study. (An American Ophthalmological Society Thesis).

Authors:  Jurij R Bilyk; Ann P Murchison; Benjamin T Leiby; Robert C Sergott; Ralph C Eagle; Laurence Needleman; Peter J Savino
Journal:  Trans Am Ophthalmol Soc       Date:  2018-06-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.